Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)

NCT04114188 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Rejection

Interventions

DRUG: Antithymocyte Immunoglobulin (Rabbit)

Sponsor

Prof. Dr. Petra Reinke

Collaborators

[object Object]